Table 5. Multivariate linear regression analyses of factors associated with EuroQoL 5-dimension index in CC patients (n = 200).
| Variables | Coefficient (95% CI) | P value | |
|---|---|---|---|
| Age | −0.001 (−0.001 to 0.001) | 0.838 | |
| Female (vs. male) | −0.039 (−0.078 to −0.001) | 0.047 | |
| Comorbidities | |||
| Asthma (vs. none) | −0.015 (−0.080 to 0.051) | 0.654 | |
| Hypertension (vs. none) | −0.022 (−0.067 to 0.023) | 0.336 | |
| Depression (vs. none) | −0.047 (−0.173 to 0.079) | 0.463 | |
| RUCC (vs. newly referred with CC) | −0.012 (−0.054 to 0.030) | 0.569 | |
| LCQ score | 0.012 (0.006 to 0.018) | < 0.001 | |
| Recent treatment with | |||
| Codeine | 0.006 (−0.035 to 0.047) | 0.775 | |
| Neuromodulators | −0.032 (−0.083 to 0.020) | 0.224 | |
| Complications | |||
| Fatigue | −0.052 (−0.092 to −0.012) | 0.011 | |
| Chest pain | −0.020 (−0.065 to −0.025) | 0.383 | |
Adjusted for age, sex, comorbidities, type of CC, cough severity, recent treatment history and cough-related complications.
CC, chronic cough; CI, confidence interval; RUCC, refractory or unexplained chronic cough; LCQ, Leicester Cough Questionnaire.